(Q47616223)

4 February 2018

title

MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway (English)

1 reference

4 February 2018

1 reference

1 reference

hepatocellular carcinoma

1 reference

Xin Yang

1

1 reference

4 February 2018

Xiao-Fei Zhang

2

1 reference

4 February 2018

Xu Lu

3

1 reference

4 February 2018

Hu-Liang Jia

4

1 reference

4 February 2018

Lei Liang

5

1 reference

4 February 2018

Qiong-Zhu Dong

6

1 reference

4 February 2018

Qing-Hai Ye

7

1 reference

4 February 2018

Lun-Xiu Qin

8

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 April 2014

1 reference

4 February 2018

published in

Hepatology

1 reference

4 February 2018

volume

59

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

1874-1885

1 reference

4 February 2018

Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy

cites work

1 reference

7 January 2021

MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression

1 reference

7 January 2021

Angiogenesis in liver disease

1 reference

7 January 2021

MicroRNAs: small RNAs with a big role in gene regulation

1 reference

7 January 2021

1 reference

7 January 2021

MicroRNAs as oncogenes and tumor suppressors

1 reference

7 January 2021

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

1 reference

7 January 2021

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

1 reference

7 January 2021

MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.

1 reference

7 January 2021

Widespread microRNA repression by Myc contributes to tumorigenesis

1 reference

7 January 2021

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

1 reference

7 January 2021

Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma

1 reference

7 January 2021

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

1 reference

7 January 2021

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway

1 reference

7 January 2021

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2

1 reference

7 January 2021

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

1 reference

7 January 2021

MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin

1 reference

7 January 2021

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

1 reference

7 January 2021

HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion

1 reference

7 January 2021

Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.

1 reference

7 January 2021

Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis

1 reference

7 January 2021

Targeting the HGF/c-MET pathway in hepatocellular carcinoma

1 reference

7 January 2021

VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway

1 reference

7 January 2021

PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines

1 reference

7 January 2021

SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway

1 reference

7 January 2021

Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways.

1 reference

7 January 2021

Targeting the tumour vasculature: insights from physiological angiogenesis

1 reference

7 January 2021

The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction

1 reference

7 January 2021

Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting

1 reference

7 January 2021

Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges

1 reference

7 January 2021

VEGF is essential for the growth and migration of human hepatocellular carcinoma cells

1 reference

7 January 2021

1 reference

7 January 2021

Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion

1 reference

7 January 2021

Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesisin lung cancer

1 reference

7 January 2021

VEGF in tumor progression and targeted therapy

1 reference

7 January 2021

miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer

1 reference

7 January 2021

SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.

1 reference

7 January 2021

Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells

1 reference

7 January 2021

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

1 reference

7 January 2021

Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration

1 reference

7 January 2021

MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein

1 reference

7 January 2021

Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26941

1 reference

4 February 2018

PubMed ID

24259426

1 reference

4 February 2018